{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:26:15Z","timestamp":1649100375467},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T00:00:00Z","timestamp":1390521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00059-013-4035-4","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T08:15:59Z","timestamp":1390378559000},"page":"15-24","source":"Crossref","is-referenced-by-count":1,"title":["Medikament\u00f6se Therapie von Herz- und Lungenerkrankungen"],"prefix":"10.1007","volume":"39","author":[{"given":"S.","family":"M\u00f6hlenkamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Voshaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Teschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,24]]},"reference":[{"key":"4035_CR1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC et al (2011) COPD clinical research network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:689\u2013698","journal-title":"N Engl J Med"},{"key":"4035_CR2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1164\/rccm.200705-656OC","volume":"176","author":"Alexeeff","year":"2007","unstructured":"Alexeeff SE, Litonjua AA, Sparrow D et al (2007) Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 176:742\u2013747","journal-title":"Am J Respir Crit Care Med"},{"key":"4035_CR3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.123.6.1964","volume":"123","author":"Au","year":"2003","unstructured":"Au DH, Udris EM, Fan VS et al (2003) Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest 123:1964\u20131969","journal-title":"Chest"},{"key":"4035_CR4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.amjmed.2004.07.043","volume":"117","author":"Au","year":"2004","unstructured":"Au DH, Bryson CL, Fan VS et al (2004) Betablockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease. Am J Med 117:925\u2013931","journal-title":"Am J Med"},{"key":"4035_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.0306-5251.2001.01560.x","volume":"53","author":"Ann","year":"2002","unstructured":"Ann Twiss M, Harman E, Chesrown S, Hendeles L (2002) Efficacy of calcium channel blockers as maintenance therapy for asthma. Br J Clin Pharmacol 53:243\u2013249","journal-title":"Br J Clin Pharmacol"},{"key":"4035_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/rccm.2110093","volume":"166","author":"Anthonisen","year":"2002","unstructured":"Anthonisen NR, Connett JE, Enright PL et al (2002) Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 166:333\u2013339","journal-title":"Am J Respir Crit Care Med"},{"key":"4035_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/pgmj.2005.040105","volume":"82","author":"Azzam","year":"2006","unstructured":"Azzam I, Tov N, Elias N, Naschitz JE (2006) Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge. Postgrad Med J 82:73\u201375","journal-title":"Postgrad Med J"},{"key":"4035_CR8","doi-asserted-by":"crossref","first-page":"289S","DOI":"10.1111\/j.1365-2125.1985.tb02815.x","volume":"20","author":"Barnes","year":"1985","unstructured":"Barnes PJ (1985) Clinical studies with calcium antagonists in asthma. Br J Clin Pharmacol 20(Suppl 2):289S\u2013298S","journal-title":"Br J Clin Pharmacol"},{"key":"4035_CR9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1592\/phco.2005.25.11.1550","volume":"25","author":"Barnett","year":"2005","unstructured":"Barnett MJ, Milavetz G, Kaboli PJ (2005) beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease. Pharmacotherapy 25:1550\u20131559","journal-title":"Pharmacotherapy"},{"key":"4035_CR10","first-page":"197","volume":"5","author":"Bateman","year":"2010","unstructured":"Bateman E, Singh D, Smith D et al (2010) Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis 5:197\u2013208","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4035_CR11","first-page":"900","volume":"117","author":"Bear","year":"1977","unstructured":"Bear R, Goldstein M, Phillipson E et al (1977) Effect of metabolic alkalosis on respiratory function in patients with chronic obstructive lung disease. Can Med Assoc J 117:900\u2013903","journal-title":"Can Med Assoc J"},{"key":"4035_CR12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/phar.1293","volume":"33","author":"Belchikov","year":"2013","unstructured":"Belchikov YG, Koenig SJ, Dipasquale EM (2013) Potential role of endogenous adenosine in ticagrelor-induced dyspnea. Pharmacotherapy 33(8):882\u2013887","journal-title":"Pharmacotherapy"},{"key":"4035_CR13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.96.09061314","volume":"9","author":"Benard","year":"1996","unstructured":"Benard A, Melloni B, Gosselin B et al (1996) Perindopril-associated pneumonitis. Eur Respir J 9:1314\u20131316","journal-title":"Eur Respir J"},{"key":"4035_CR14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1742-1241.2008.01731.x","volume":"62","author":"Blamoun","year":"2008","unstructured":"Blamoun AI, Batty GN, DeBari VA et al (2008) Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 62:1373\u20131378","journal-title":"Int J Clin Pract"},{"key":"4035_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1989.03420030087036","volume":"261","author":"Boulet","year":"1989","unstructured":"Boulet LP, Milot J, Lampron N, Lacourci\u00e8re Y (1989) Pulmonary function and airway responsiveness during long-term therapy with captopril. JAMA 261:413\u2013416","journal-title":"JAMA"},{"key":"4035_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bmj.296.6615.86","volume":"J","author":"Bucknall","year":"1988","unstructured":"Bucknall CE, Neilly JB, Carter R et al (1988) Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br Med J (Clin Res Ed) 296:86\u201388","journal-title":"Br Med"},{"key":"4035_CR17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1185\/03007995.2013.781502","volume":"29","author":"Butler","year":"2013","unstructured":"Butler K, Maya J, Teng R (2013) Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients. Curr Med Res Opin 29:569\u2013577","journal-title":"Curr Med Res Opin"},{"key":"4035_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pupt.2006.06.003","volume":"20","author":"Campbell","year":"2007","unstructured":"Campbell SC, Criner GJ, Levine BE et al (2007) Cardiac safety of formoterol 12\u00a0microg twice daily in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 20:571\u2013579","journal-title":"Pulm Pharmacol Ther"},{"key":"4035_CR19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775\u2013789","journal-title":"N Engl J Med"},{"key":"4035_CR20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/thx.44.9.711","volume":"44","author":"Camus","year":"1989","unstructured":"Camus P, Lombard JN, Perrichon M et al (1989) Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 44:711\u2013715","journal-title":"Thorax"},{"key":"4035_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.09-0011","volume":"137","author":"Celli","year":"2010","unstructured":"Celli B, Decramer M, Leimer I et al (2010) Cardiovascular safety of tiotropium in patients with COPD. Chest 137:20\u201330","journal-title":"Chest"},{"key":"4035_CR22","first-page":"Jan","volume":"update","author":"Chan","year":"2013","unstructured":"Chan ED, King TE (2013) Pulmonary disease induced by cardiovascular drugs. UpToDate. http:\/\/www.uptodate.com. Last update: Jan 18, 2013","journal-title":"Last"},{"key":"4035_CR23","unstructured":"Chan ED, King TE (2013) Amiodarone pulmonary toxicity. UpToDate. http:\/\/www.uptodate.com. Last update: Dez 24, 2012 (literature review current through: Sep 2013)"},{"key":"4035_CR24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.clinthera.2012.04.005","volume":"34","author":"Cheng","year":"2012","unstructured":"Cheng JW (2012) Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes. Clin Ther 34(6):1209\u20131220","journal-title":"Clin Ther"},{"key":"4035_CR25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/cpt1979256800","volume":"25","author":"Cody","year":"1979","unstructured":"Cody RJ Jr, Calabrese LH, Clough JD et al (1979) Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther 25:800\u2013805","journal-title":"Clin Pharmacol Ther"},{"key":"4035_CR26","doi-asserted-by":"crossref","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","volume":"129","author":"Dicpinigaitis","year":"2006","unstructured":"Dicpinigaitis PV (2006) Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129:169S\u2013173S","journal-title":"Chest"},{"key":"4035_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcp\/87.1.7","volume":"87","author":"Dean","year":"1987","unstructured":"Dean PJ, Groshart KD, Porterfield JG et al (1987) Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol 87:7\u201313","journal-title":"Am J Clin Pathol"},{"key":"4035_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/thx.2007.081893","volume":"63","author":"Dransfield","year":"2008","unstructured":"Dransfield MT, Rowe SM, Johnson JE et al (2008) Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 63:301\u2013305","journal-title":"Thorax"},{"key":"4035_CR29","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1183\/09031936.97.10092159","volume":"10","author":"Faller","year":"1997","unstructured":"Faller M, Quoix E, Popin E et al (1997) Migratory pulmonary infiltrates in a patient treated with sotalol. Eur Respir J 10:2159\u20132162","journal-title":"Eur Respir J"},{"key":"4035_CR30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1378\/chest.123.6.1817","volume":"123","author":"Ferguson","year":"2003","unstructured":"Ferguson GT, Funck-Brentano C, Fischer T et al (2003) Cardiovascular safety of salmeterol in COPD. Chest 123:1817\u20131824","journal-title":"Chest"},{"key":"4035_CR31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","volume":"134","author":"Fernandez","year":"2008","unstructured":"Fernandez AB, Karas RH, Alsheikh-Ali AA, Thompson PD (2008) Statins and interstitial lung disease \u2013 a systematic review of the literature and of food and drug administration adverse event reports. Chest 134:824\u2013830","journal-title":"Chest"},{"key":"4035_CR32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","volume":"339","author":"Gottlieb","year":"1998","unstructured":"Gottlieb SS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339:489\u2013497","journal-title":"N Engl J Med"},{"key":"4035_CR33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfp001","volume":"11","author":"Hawkins","year":"2009","unstructured":"Hawkins NM, Huang Z, Pieper KS et al (2009) Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail 11(3):292\u2013298","journal-title":"Eur J Heart Fail"},{"key":"4035_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/COPD.S4620","volume":"4","author":"Hilleman","year":"2009","unstructured":"Hilleman DE, Malesker MA, Morrow LE, Schuller D (2009) A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD. Int J Chron Obstruct Pulmon Dis 4:253\u2013263","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4035_CR35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","volume":"37","author":"Irons","year":"2003","unstructured":"Irons BK, Kumar A (2003) Valsartan-induced angioedema. Ann Pharmacother 37:1024\u20131027","journal-title":"Ann Pharmacother"},{"key":"4035_CR36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","volume":"117","author":"Israili","year":"1992","unstructured":"Israili ZH, Hall WD (1992) Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 117:234\u2013242","journal-title":"Ann Intern Med"},{"key":"4035_CR37","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.ijcard.2013.06.034","volume":"168","author":"Jensen","year":"2013","unstructured":"Jensen MT, Kaiser C, Sandsten KE et al (2013) Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes \u2013 results from the BASKET PROVE trial. Int J Cardiol 168(4):3802\u20133806","journal-title":"Int J Cardiol"},{"key":"4035_CR38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.00072212","volume":"42","author":"Jensen","year":"2013","unstructured":"Jensen MT, Marott JL, Lange P et al (2013) Resting heart rate is a predictor of mortality in COPD. Eur Respir J 42(2):341\u2013349","journal-title":"Eur Respir J"},{"key":"4035_CR39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1378\/chest.95.3.544","volume":"95","author":"Kaufman","year":"1989","unstructured":"Kaufman J, Casanova JE, Riendl P, Schlueter DP (1989) Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 95:544\u2013548","journal-title":"Chest"},{"key":"4035_CR40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/bmj.299.6705.981","volume":"299","author":"Kidney","year":"1989","unstructured":"Kidney JC, O\u2019Halloran DJ, FitzGerald MX (1989) Captopril and lymphocytic alveolitis. BMJ 299:981","journal-title":"BMJ"},{"key":"4035_CR41","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1053-2498(02)00459-X","volume":"21","author":"Kotlyar","year":"2002","unstructured":"Kotlyar E, Keogh AM, Macdonald PS et al (2002) Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. J Heart Lung Transplant 21:1290\u20131295","journal-title":"J Heart Lung Transplant"},{"key":"4035_CR42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/heart.84.6.615","volume":"84","author":"Krum","year":"2000","unstructured":"Krum H, Ninio D, MacDonald P (2000) Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart 84:615\u2013619","journal-title":"Heart"},{"key":"4035_CR43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pupt.2012.10.008","volume":"26","author":"Lahousse","year":"2013","unstructured":"Lahousse L, Loth DW, Joos GF et al (2013) Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther 26:212\u2013217","journal-title":"Pulm Pharmacol Ther"},{"key":"4035_CR44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2007.09.102","volume":"101","author":"Lee","year":"2008","unstructured":"Lee TM, Lin MS, Chang NC (2008) Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 101:530\u2013535","journal-title":"Am J Cardiol"},{"key":"4035_CR45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9343(89)90438-5","volume":"86","author":"Lipworth","year":"1989","unstructured":"Lipworth BJ, McDevitt DG, Struthers AD (1989) Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol. Am J Med 86:653\u2013657","journal-title":"Am J Med"},{"key":"4035_CR46","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1183\/09031936.00095909","volume":"35","author":"Loke","year":"2010","unstructured":"Loke YK, Kwok CS, Singh S (2010) Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD. Eur Respir J 35:1003\u20131021","journal-title":"Eur Respir J"},{"key":"4035_CR47","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1344642","volume":"67","author":"Lorenz","year":"2013","unstructured":"Lorenz J, Bals R, Magnussen H et al (2013) Expertentreffen obstruktive Atemwegserkrankungen: Kardiovaskul\u00e4re Aspekte der COPD. Pneumologie 67(12):663\u2013675","journal-title":"Pneumologie"},{"key":"4035_CR48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.308.6920.18","volume":"308","author":"Lunde","year":"1994","unstructured":"Lunde H, Hedner T, Samuelsson O et al (1994) Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 308:18\u201321","journal-title":"BMJ"},{"key":"4035_CR49","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","volume":"47","author":"Mancini","year":"2006","unstructured":"Mancini GB, Etminan M, Zhang B et al (2006) Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 47:2554\u20132560","journal-title":"J Am Coll Cardiol"},{"key":"4035_CR50","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1378\/chest.93.5.1067","volume":"93","author":"Martin","year":"1988","unstructured":"Martin WJ 2nd, Rosenow EC 3rd (1988) Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 1). Chest 93:1067\u20131075","journal-title":"Chest"},{"key":"4035_CR51","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1378\/chest.93.6.1242","volume":"93","author":"Martin","year":"1988","unstructured":"Martin WJ 2nd, Rosenow EC 3rd (1988) Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest 93:1242\u20131248","journal-title":"Chest"},{"key":"4035_CR52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","volume":"3","author":"Martinez","year":"2008","unstructured":"Martinez FJ, Curtis JL, Albert R (2008) Role of macrolide therapy in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 3:331\u2013350","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4035_CR53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM198702193160807","volume":"316","author":"Mason","year":"1987","unstructured":"Mason JW (1987) Amiodarone. N Engl J Med 316:455\u2013466","journal-title":"N Engl J Med"},{"key":"4035_CR54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","volume":"148","author":"Matchar","year":"2008","unstructured":"Matchar DB, McCrory DC, Orlando LA et al (2008) Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 148:16\u201329","journal-title":"Ann Intern Med"},{"key":"4035_CR55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0007-0971(78)90062-1","volume":"72","author":"McGavin","year":"1978","unstructured":"McGavin CR, Williams IP (1978) The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction. Br J Dis Chest 72:327\u2013332","journal-title":"Br J Dis Chest"},{"key":"4035_CR56","doi-asserted-by":"crossref","unstructured":"Merola JF (2012) Lupus-like syndromes related to drugs. In: Schur PH, Massarotti E (Eds) Lupus erythematosus: clinical evaluation and treatment. Springer, New York, S\u00a0211\u2013221","DOI":"10.1007\/978-1-4614-1189-5_16"},{"key":"4035_CR57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMp1008502","volume":"363","author":"Michele","year":"2010","unstructured":"Michele TM, Pinheiro S, Iyasu S (2010) The safety of tiotropium \u2013 the FDA\u2019s conclusions. N Engl J Med 363:1097\u20131099","journal-title":"N Engl J Med"},{"key":"4035_CR58","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","volume":"368","author":"Mosholder","year":"2013","unstructured":"Mosholder AD, Mathew J, Alexander JJ et al (2013) Cardiovascular risks with azithromycin and other antibacterial drugs. N Engl J Med 368:1665\u20131668","journal-title":"N Engl J Med"},{"key":"4035_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0046-8177(87)80164-8","volume":"18","author":"Myers","year":"1987","unstructured":"Myers JL, Kennedy JI, Plumb VJ (1987) Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 18:349\u2013354","journal-title":"Hum Pathol"},{"key":"4035_CR60","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.126.2.438","volume":"126","author":"Nadrous","year":"2004","unstructured":"Nadrous HF, Ryu JH, Douglas WW et al (2004) Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 126:438\u2013446","journal-title":"Chest"},{"key":"4035_CR61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1378\/chest.08-2367","volume":"137","author":"Ogale","year":"2010","unstructured":"Ogale SS, Lee TA, Au DH et al (2010) Cardiovascular events associated with ipratropium bromide in COPD. Chest 137:13\u201319","journal-title":"Chest"},{"key":"4035_CR62","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"ONTARGET","year":"2008","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547\u20131559","journal-title":"N Engl J Med"},{"key":"4035_CR63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-6749(87)90247-8","volume":"79","author":"Patakas","year":"1987","unstructured":"Patakas D, Maniki E, Tsara V, Dascalopoulou E (1987) Nifedipine treatment of patients with bronchial asthma. J Allergy Clin Immunol 79:959\u2013963","journal-title":"J Allergy Clin Immunol"},{"key":"4035_CR64","first-page":"75","volume":"22","author":"Pigakis","year":"2009","unstructured":"Pigakis K, Ferdoutsis M, Meletis G et al (2009) Pulmonary toxicity from cardiovascular drugs. Pneumon 22:75\u201384","journal-title":"Pneumon"},{"key":"4035_CR65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","volume":"130","author":"Provencher","year":"2006","unstructured":"Provencher S, Herve P, Jais X et al (2006) Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 130:120\u2013126","journal-title":"Gastroenterology"},{"key":"4035_CR66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1378\/chest.12-1395","volume":"142","author":"Rabe","year":"2012","unstructured":"Rabe KF (2012) Drug safety in COPD revisited: what is the number needed to analyze? Chest 142:271\u2013274","journal-title":"Chest"},{"key":"4035_CR67","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","volume":"366","author":"Ray","year":"2012","unstructured":"Ray WA, Murray KT, Hall K et al (2012) Azithromycin and the risk of cardiovascular death. N Engl J Med 366:1881\u20131890","journal-title":"N Engl J Med"},{"key":"4035_CR68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-95-3-326","volume":"95","author":"Record","year":"1981","unstructured":"Record NB Jr (1981) Acebutolol-induced pleuropulmonary lupus syndrome. Ann Intern Med 95:326\u2013327","journal-title":"Ann Intern Med"},{"key":"4035_CR69","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/all.12199","volume":"68","author":"Reiter","year":"2013","unstructured":"Reiter J, Demirel N, Mendy A et al (2013) Macrolides for the long-term management of asthma \u2013 a meta-analysis of randomized clinical trials. Allergy 68:1040\u20131049","journal-title":"Allergy"},{"key":"4035_CR70","first-page":"CD003566","volume":"Rev","author":"Salpeter","year":"2002","unstructured":"Salpeter SS, Ormiston T, Salpeter E et al (2002) Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD003566","journal-title":"Cochrane Database Syst"},{"key":"4035_CR71","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","volume":"125","author":"Salpeter","year":"2004","unstructured":"Salpeter SR, Ormiston TM, Salpeter EE (2004) Cardiovascular effects of betaagonists in patients with asthma and COPD: a meta-analysis. Chest 125:2309\u20132321","journal-title":"Chest"},{"key":"4035_CR72","first-page":"262","volume":"134","author":"Schwartzstein","year":"1986","unstructured":"Schwartzstein RS, Fanta CH (1986) Orally administered nifedipine in chronic stable asthma. Comparison with an orally administered sympathomimetic. Am Rev Respir Dis 134:262\u2013265","journal-title":"Am Rev Respir Dis"},{"key":"4035_CR73","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.159.9.989","volume":"159","author":"Shannon","year":"1999","unstructured":"Shannon M (1999) Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med 159:989\u2013994","journal-title":"Arch Intern Med"},{"key":"4035_CR74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1378\/chest.95.3.685","volume":"95","author":"Schatz","year":"1989","unstructured":"Schatz PL, Mesologites D, Hyun J et al (1989) Captopril-induced hypersensitivity lung disease. An immune-complex-mediated phenomenon. Chest 95:685\u2013687","journal-title":"Chest"},{"key":"4035_CR75","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","volume":"342","author":"Short","year":"2011","unstructured":"Short PM, Lipworth SI, Elder DH et al (2011) Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 342:d2549","journal-title":"BMJ"},{"key":"4035_CR76","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","volume":"300","author":"Singh","year":"2008","unstructured":"Singh S, Loke YK, Furberg CD (2008) Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 300:1439\u20131450","journal-title":"JAMA"},{"key":"4035_CR77","doi-asserted-by":"crossref","first-page":"d3215","DOI":"10.1136\/bmj.d3215","volume":"342","author":"Singh","year":"2011","unstructured":"Singh S, Loke YK, Enright PL, Furberg CD (2011) Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 342:d3215","journal-title":"BMJ"},{"key":"4035_CR78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/thorax.58.1.43","volume":"58","author":"Suissa","year":"2003","unstructured":"Suissa S, Assimes T, Ernst P (2003) Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Thorax 58:43\u201346","journal-title":"Thorax"},{"key":"4035_CR79","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.amjcard.2011.07.015","volume":"108","author":"Storey","year":"2011","unstructured":"Storey RF, Becker RC, Harrington RA et al (2011) Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Am J Cardiol 108:1542\u20131546","journal-title":"Am J Cardiol"},{"key":"4035_CR80","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","volume":"368","author":"Svanstr\u00f6m","year":"2013","unstructured":"Svanstr\u00f6m H, Pasternak B, Hviid A (2013) Use of azithromycin and death from cardiovascular causes. N Engl J Med 368:1704\u20131712","journal-title":"N Engl J Med"},{"key":"4035_CR81","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2012.01.020","volume":"59","author":"Swedberg","year":"2012","unstructured":"Swedberg K, Komajda M, B\u00f6hm M et al (2012) Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. J Am Coll Cardiol 59:1938\u20131945","journal-title":"J Am Coll Cardiol"},{"key":"4035_CR82","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.hlc.2010.01.008","volume":"19","author":"Tanawuttiwat","year":"2010","unstructured":"Tanawuttiwat T, Harindhanavudhi T, Hanif S, Sahloul MZ (2010) Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication. Heart Lung Circ 19:435\u2013437","journal-title":"Heart Lung Circ"},{"key":"4035_CR83","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M et al (2012) Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 172:1582\u20131589","journal-title":"Arch Intern Med"},{"key":"4035_CR84","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.95.08030470","volume":"8","author":"Valle","year":"1995","unstructured":"Valle JM, Alvarez D, Ant\u00fanez J, Vald\u00e9s L (1995) Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology. Eur Respir J 8:470\u2013471","journal-title":"Eur Respir J"},{"key":"4035_CR85","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","volume":"166","author":"Hooft","year":"2006","unstructured":"Hooft CS van der, Heeringa J, Brusselle GG et al (2006) Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 166:1016\u20131020","journal-title":"Arch Intern Med"},{"key":"4035_CR86","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjcard.2008.03.038","volume":"102","author":"Gestel","year":"2008","unstructured":"Gestel YR van, Hoeks SE, Sin DD et al (2008) Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol 102:192\u2013196","journal-title":"Am J Cardiol"},{"key":"4035_CR87","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1001\/archinte.158.18.2063","volume":"158","author":"Rijnsoever","year":"1998","unstructured":"Rijnsoever EW van, Kwee-Zuiderwijk WJ, Feenstra J (1998) Angioneurotic edema attributed to the use of losartan. Arch Intern Med 158:2063\u20132065","journal-title":"Arch Intern Med"},{"key":"4035_CR88","doi-asserted-by":"crossref","first-page":"e65638","DOI":"10.1371\/journal.pone.0065638","volume":"8","author":"Warnier","year":"2013","unstructured":"Warnier MJ, Blom MT, Bardai A et al (2013) Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study. PLoS One 8(6):e65638","journal-title":"PLoS One"},{"key":"4035_CR89","first-page":"Sept","volume":"update","author":"Weinberger","year":"2013","unstructured":"Weinberger SE, Kaplan NM (2013) Treatment of hypertension in asthma and COPD. UpToDate. http:\/\/www.uptodate.com. Last update: Sept 09, 2013","journal-title":"Last"},{"key":"4035_CR90","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-2332","volume":"144","author":"White","year":"2013","unstructured":"White WB, Cooke GE, Kowey PR et al (2013) Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. Chest 144(3):758\u2013765","journal-title":"Chest"},{"key":"4035_CR91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1378\/chest.1390901","volume":"142","author":"Wilchesky","year":"2012","unstructured":"Wilchesky M, Ernst P, Brophy JM et al (2012) Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest 142:298\u2013304","journal-title":"Chest"},{"key":"4035_CR92","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.1389943","volume":"142","author":"Wilchesky","year":"2012","unstructured":"Wilchesky M, Ernst P, Brophy JM et al (2012) Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest 142:305\u2013311","journal-title":"Chest"},{"key":"4035_CR93","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/0140-6736(90)93099-B","volume":"336","author":"Wong","year":"1990","unstructured":"Wong CS, Pavord ID, Williams J et al (1990) Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336:1396\u20131399","journal-title":"Lancet"},{"key":"4035_CR94","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.rmed.2010.11.027","volume":"105","author":"Worth","year":"2011","unstructured":"Worth H, Chung KF, Felser JM et al (2011) Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD. Respir Med 105:571\u2013579","journal-title":"Respir Med"},{"key":"4035_CR95","first-page":"254","volume":"17","author":"Zitnik","year":"1996","unstructured":"Zitnik RJ (1996) Drug-induced lung disease: antiarrhythmic agents. J Respir Dis 17:254\u2013270","journal-title":"J Respir Dis"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-4035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-013-4035-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-013-4035-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T22:11:54Z","timestamp":1565129514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-013-4035-4"}},"subtitle":["Effekte auf das jeweils andere Organ"],"short-title":[],"issued":{"date-parts":[[2014,1,24]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["4035"],"URL":"https:\/\/doi.org\/10.1007\/s00059-013-4035-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,24]]}}}